Related Experiment Video
Updated: May 16, 2026
13:04
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Borderline ovarian tumors: features and controversial aspects.
Enrico M Messalli1, Flavio Grauso, Giancarlo Balbi
1Department of Gynecologic, Obstetric and Reproduction Sciences, Second University of Naples, Naples, Italy. enricom.messalli@unina2.it
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|December 11, 2012
Summary
Borderline ovarian tumors (BOT) are often diagnosed at early stages and can be treated with conservative surgery, especially for women desiring future pregnancies. Long-term follow-up is crucial for advanced stages.
Area of Science:
- Gynecologic Oncology
- Pathology
- Reproductive Medicine
Background:
- Borderline ovarian tumors (BOT) constitute 10-15% of epithelial ovarian neoplasms.
- BOTs exhibit a generally favorable prognosis compared to malignant ovarian cancers.
- Understanding BOT features is crucial for appropriate patient management and treatment strategies.
Purpose of the Study:
- To investigate the clinical features and controversial aspects of borderline ovarian tumors (BOT).
- To evaluate the prognostic factors and treatment outcomes for BOT patients.
- To assess the role of tumor markers in the management of BOT.
Main Methods:
- Retrospective analysis of 43 patients treated for BOT between 2000 and 2010.
- Data collected included patient demographics, surgical procedures, tumor characteristics, and pre/post-operative tumor marker levels (CA125, CA19.9, CA15.3, CEA).
- Overall survival (OS) and progression-free survival (PFS) were assessed.
Main Results:
- The median patient age was 49 years; 74% were diagnosed at FIGO stage IA.
- Serous histotype was most prevalent; 49% of patients were asymptomatic.
- Pre-operative elevated CA125 normalized post-surgery in all cases; 5-year and 60-month PFS were 96% and 77%, respectively.
Conclusions:
- Early-stage BOT (IA and IB) behaves more like a benign tumor, supporting conservative surgery for fertility preservation.
- Advanced-stage BOT necessitates careful, long-term patient follow-up.
- CA125, despite limitations, plays a role in monitoring BOT patients.
Related Concept Videos
01:26Ovaries
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of cuboidal...
On the ovarian surface, a layer of cuboidal...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...